BL-M17D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-M17D1, covering 2025-09-18 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors [Phase 1]

See pricing